Osr Holdings Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.32

-0.01 (-3.89%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,071.3% upside

Low Target $2.62

Average Target $3.76

High Target $5.13

Current Price $0.32

Current
$0.32

Target
$3.76

$2.62 $3.76 avg $5.13

Scenario Analysis

Bear Case

$2.62

716.2%

Low target

Base Case

$3.76

+1,071.3%

Avg target

Bull Case

$5.13

+1,498.1%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$1.57

-79.6% from high

52-Week Low

$0.32

+1.9% from low

Target vs 52W High

$3.76

+139.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.2%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.6%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-40.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.0%